Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jackson

Showing results (441-450 of 517) with videos related to

Pageof 52
Sort By:
The Journal of Clinical Investigation|March 1, 1983
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisolD N Orth, R V Jackson, G S DeCherney, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|June 11, 2015
Engaging staff to improve quality and safety in an austere medical environment: a case-control study in two Sierra Leonean hospitalsMichael A Rosen, Adaora M Chima, John B Sampson, et al.
American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology AssociationF Richards, L D Case, D R White, et al.
Clinical and Experimental Pharmacology & Physiology|September 19, 2001
Early rise in blood pressure following administration of adrenocorticotropic hormone-[1-24] in humansR V Jackson, E J Nye, J E Grice, et al.
American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysisB L Powell, D V Jackson, C W Scarantino, et al.
Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.
Cancer Investigation|January 1, 1987
Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristineD V Jackson, C L Spurr, M E Caponera, et al.
Circulation|September 1, 1990
Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosisC V Jackson, V G Crowe, T J Craft, et al.
Pageof 52

Showing results (441-450 of 517) with videos related to

Sort By:
Pageof 52
The Journal of Clinical Investigation|March 1, 1983
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisolD N Orth, R V Jackson, G S DeCherney, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|June 11, 2015
Engaging staff to improve quality and safety in an austere medical environment: a case-control study in two Sierra Leonean hospitalsMichael A Rosen, Adaora M Chima, John B Sampson, et al.
American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology AssociationF Richards, L D Case, D R White, et al.
Clinical and Experimental Pharmacology & Physiology|September 19, 2001
Early rise in blood pressure following administration of adrenocorticotropic hormone-[1-24] in humansR V Jackson, E J Nye, J E Grice, et al.
American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysisB L Powell, D V Jackson, C W Scarantino, et al.
Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.
Cancer Investigation|January 1, 1987
Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristineD V Jackson, C L Spurr, M E Caponera, et al.
Circulation|September 1, 1990
Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosisC V Jackson, V G Crowe, T J Craft, et al.
Pageof 52